LFST
$12.70
+$0.47 (3.89%)+3.89%
OpenLoading chart...
IndexN/A
Market Cap4.92B
Enterprise Value2.66B
Income$0.00B
Sales$0.33B
EmployeesN/A
P/E95.61
P/S1.91
P/B1.79
P/C24.70
EV/EBITDA33.80
EV/SalesN/A
EPS (ttm)0.13
EarningsN/A
Gross Margin32.37%
Oper. Margin1.70%
Profit Margin0.68%
Volume2.86M
Shs Outstand0.39B
Change3.88%
Dividend Est.N/A
Dividend Ex-DateN/A
Perf YTDN/A
Perf YearN/A
Perf 3YN/A
Perf 5YN/A
Perf 10YN/A
IPON/A
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue | $1.25B | $1.06B | $859.54M | $667.51M | $377.22M | $212.52M |
| Cost of Revenue | $848.57M | $753.57M | $622.52M | $466.00M | $242.90M | $150.12M |
| Gross Profit | $402.40M | $302.10M | $237.02M | $201.51M | $134.32M | $62.40M |
| Gross Margin | 32.17% | 28.62% | 27.57% | 30.19% | 35.61% | 29.36% |
| Operating Expenses | $434.01M | $491.23M | $447.19M | $487.86M | $118.88M | $47.16M |
| Operating Income | $-31.61M | $-189.13M | $-210.17M | $-286.35M | $15.44M | $15.24M |
| Operating Margin | -2.53% | -17.92% | -24.45% | -42.90% | 4.09% | 7.17% |
| Net Income | $-57.44M | $-186.26M | $-215.56M | $-307.20M | $-38.07M | $5.67M |
| Net Margin | -4.59% | -17.64% | -25.08% | -46.02% | -10.09% | 2.67% |
| EPS (Basic) | $-0.15 | $-0.51 | $-0.61 | $-1.05 | $-0.83 | $0.02 |
| EBITDA | N/A | N/A | N/A | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | N/A | N/A | N/A | N/A | N/A | N/A |
| Short Term Receivables | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventories | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Assets | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Property, Plant & Equipment | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Investments and Advances | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Note Receivable | N/A | N/A | N/A | N/A | N/A | N/A |
| Intangible Assets | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Assets | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Assets | $2.12B | $2.11B | $2.17B | $1.93B | $1.57B | $280.78M |
| Short Term Debt Incl. Current Port. of LT Debt | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax Payable | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A |
| Provision for Risks Charges | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Liabilities | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $672.01M | $681.04M | $655.15M | $382.08M | $571.89M | $447.13M |
| Non-Equity Reserves | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Stock - Carrying Value | N/A | N/A | N/A | N/A | N/A | N/A |
| Common Equity | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Shareholders Equity | $1.45B | $1.43B | $1.52B | $1.55B | $997.84M | $-166.35M |
| Accumulated Minority Interest | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $1.45B | $1.43B | $1.52B | $1.55B | $997.84M | $-166.35M |
| Total Liabilities & Stockholders Equity | $2.12B | $2.11B | $2.17B | $1.93B | $1.57B | $280.78M |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A |
| Tangible Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A |
| Full-Time Employees | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Book Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Net Income | $-57.44M | $-186.26M | $-215.56M | $-307.20M | $-38.07M | $5.67M |
| Depreciation | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Funds (Non Cash) | N/A | N/A | N/A | N/A | N/A | N/A |
| Funds from Operations | N/A | N/A | N/A | N/A | N/A | N/A |
| Extraordinary Item | N/A | N/A | N/A | N/A | N/A | N/A |
| Changes in Working Capital | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Taxes Payable | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Operating Activities | $107.26M | $-16.88M | $52.79M | $9.42M | $-8.53M | $17.05M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Assets From Acquisitions | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Fixed Assets and Businesses | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase or Sale of Investments | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase of Investments | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale Or Maturity of Investments | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Uses | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Sources | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Investing Activities | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Capital Stock | N/A | N/A | N/A | N/A | N/A | N/A |
| Repurchase of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A |
| Proceeds from Stock Options | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance or Reduction of Debt, Net | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A |
| Reduction of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Financing Active Other Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Financing Activities Uses | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Financing Activities | N/A | N/A | N/A | N/A | N/A | N/A |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Change in Cash | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Dividends (Cash Flow) | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A |
Company coverage
Latest news
LifeStance Health Group Announces Pricing of Secondary Public OfferingGlobeNewswire Inc. LifeStance Reports First Quarter 2026 ResultsGlobeNewswire Inc. A LifeStance Health Insider Sold Nearly 70,000 Shares. Here's What That Means for Investors.The Motley Fool Emotional Counseling Service Market Report 2026-2035: A $21.21 Billion Industry by 2030 with Cleveland Clinic, Teladoc Health., LifeStance, GoodRx, Thriveworks, Headspace, Lyra Health, MDLive LeadingGlobeNewswire Inc. Grief Counselling Market Report 2026-2035: A $5.83 Billion Industry by 2030 with Cleveland Clinic, LifeStance Health, VITAS Healthcare, and Talkspace LeadingGlobeNewswire Inc. Presidio Appoints Paula Cipollone Chief Transformation OfficerGlobeNewswire Inc. LifeStance Reports First Quarter 2025 ResultsGlobeNewswire Inc. LifeStance Reports Fourth Quarter and Full Year 2024 ResultsGlobeNewswire Inc.
Show 12 more stories
Wall Street Analysts Think LifeStance Health Could Surge 26.68%: Read This Before Placing a BetBenzinga Lifeist Explores Legal Options Regarding Hedge Fund SettlementGlobeNewswire Inc. Down -8.97% in 4 Weeks, Here's Why You Should You Buy the Dip in LifeStance Health (LFST)Zacks Investment Research Mikra Completes Design of New Product and Advances Shipment DateGlobeNewswire Inc. LifeStance to Participate in Upcoming Investor ConferencesGlobeNewswire Inc. LifeStance Health Group Announces Pricing of Secondary Public OfferingGlobeNewswire Inc. LifeStance Health Group Announces Launch of Secondary Public OfferingGlobeNewswire Inc. Lifeist Announces TSXV Approval of Common Share ConsolidationGlobeNewswire Inc. LifeStance Health Group (LFST) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0GlobeNewswire Inc. LifeStance Reports First Quarter 2024 ResultsGlobeNewswire Inc. RadNet (RDNT) Q1 Earnings and Revenues Surpass EstimatesZacks Investment Research
Insider Trading
View AllInsider
Type
Shares
Price
Value
Date
Company
About the company
LifeStance Health Group, Inc. specializes in delivering outpatient mental healthcare services through its subsidiary network. The company offers a comprehensive array of mental health solutions, encompassing psychiatric evaluations and treatment, specialized psychological and neuropsychological testing, and diverse therapeutic modalities including individual, family, and group therapy sessions. The organization addresses a wide spectrum of mental health conditions, ranging from common issues like anxiety and depression to more complex challenges such as bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. Patients have access to care through various channels: virtually via its online platform or in-person at its many centers located throughout 32 states. LifeStance is dedicated to supporting individuals across all age groups, providing care for children, adolescents, adults, and the elderly. LifeStance Health Group, Inc. was founded in 2017 and its main offices are situated in Scottsdale, Arizona.
Discover more
You may be interested in